Marek Jutel to Follow-Up Studies
This is a "connection" page, showing publications Marek Jutel has written about Follow-Up Studies.
Connection Strength
0.012
-
Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season. J Allergy Clin Immunol. 2018 08; 142(2):678-680.e7.
Score: 0.012